Faulk Pharmaceuticals, Inc.
Records under this name other than patents Faulk Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Faulk Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,420,665 | Anti-Cancer Compounds Formerly held Lapsed on the fee record Ended Apr 16, 2025 · High confidence | Lapsed on the fee record | Ended Apr 16, 2025 | High confidence |
| US 8,183,208 | Targeted delivery of drugs for the treatment of viral infections Formerly held Term ended Term ended Dec 29, 2022 · USPTO record | Term ended | Term ended Dec 29, 2022 | USPTO record |
| US 7,101,842 | Targeted delivery of drugs for the treatment of parasitic infections Formerly held Term ended Term ended Oct 29, 2022 · USPTO record | Term ended | Term ended Oct 29, 2022 | USPTO record |
| US 7,001,991 | Targeted delivery of bioaffecting compounds for the treatment of cancer Formerly held Term ended Ended no later than May 15, 2022 · USPTO record | Term ended | Ended no later than May 15, 2022 | USPTO record |
| US 7,417,023 | Targeted delivery of bioaffecting compounds for the treatment of cancer Formerly held Term ended Term ended May 15, 2022 · USPTO record | Term ended | Term ended May 15, 2022 | USPTO record |
| US 4,886,780 | Conjugates of apotransferrin proteins with anti-tumor agents Formerly held Term ended Term ended no later than Dec 12, 2009 · Low confidence | Term ended | Term ended no later than Dec 12, 2009 | Low confidence |
| US 4,895,714 | Radioiodinated apotransferrin for use in tumor diagnosis, imaging, localization or treatment Formerly held Term ended Term ended no later than Jan 23, 2010 · Low confidence | Term ended | Term ended no later than Jan 23, 2010 | Low confidence |
| US 5,000,935 | Treatment method utilizing transferrin-radioiodine conjugate Formerly held Term ended Term ended no later than Mar 19, 2011 · Low confidence | Term ended | Term ended no later than Mar 19, 2011 | Low confidence |
| US 5,108,987 | Conjugates of proteins with anti-tumor agents Formerly held Term ended Term ended no later than Apr 28, 2012 · Low confidence | Term ended | Term ended no later than Apr 28, 2012 | Low confidence |